臨床検査62巻1号

2018年01月発行

今月の特集2 心腎連関を理解する

糖尿病と心腎連関

著者： 中司敦子¹ 和田淳¹

所属機関： ¹岡山大学大学院医歯薬学総合研究科腎・免疫・内分泌代謝内科学

ページ範囲：P.72 - P.77

Point

●インスリン抵抗性や糖尿病は心腎症候群を形成する主要な病態である．

●正常アルブミン尿の範囲であっても，微量アルブミン尿は心血管疾患や死亡リスクと相関する．

●微量アルブミン尿の出現は全身の血管内皮機能障害を反映し，潜在的な臓器障害の存在を示唆している．

参考文献

1）Boudina S, Abel ED：Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord　11：31-39，2010

2）Kannel WB, McGee DL：Diabetes and cardiovascular disease. The Framingham study. JAMA　241：2035-2038，1979

3）Ferrannini E, Mark M, Mayoux E：CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis. Diabetes Care　39：1108-1114，2016

4）Kataoka S, Gohbara M, Iwahashi N, et al：Glycemic Variability on Continuous Glucose Monitoring System Predicts Rapid Progression of Non-Culprit Lesions in Patients With Acute Coronary Syndrome. Circ J　79：2246-2254，2015

5）Ceriello A：The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev　16：125-132，2000

6）Monnier L, Mas E, Ginet C, et al：Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA　295：1681-1687，2006

7）Horita S, Seki G, Yamada H, et al：Insulin resistance, obesity, hypertension, and renal sodium transport. Int J Hypertens　2011：391762，2011

8）Karalliedde J, Gnudi L：Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrol Dial Transplant　31：206-213，2016

9）Gerstein HC, Mann JF, Yi Q, et al：Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA　286：421-426，2001

10）Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al：Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet　375：2073-2081，2010

11）Yu Y, Suo L, Yu H, et al：Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria. Diabetes Res Clin Pract　65：95-104，2004

12）Yokoyama H, Aoki T, Imahori M, et al：Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int　66：448-454，2004

13）Bartz SK, Caldas MC, Tomsa A, et al：Urine Albumin-to-Creatinine Ratio: A Marker of Early Endothelial Dysfunction in Youth. J Clin Endocrinol Metab　100：3393-3399，2015

14）El-Atat FA, Stas SN, McFarlane SI, et al：The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol　15：2816-2827，2004

15）de Zeeuw D：Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney Int Suppl　S2-S6，2004